✦ LIBER ✦

Cost-Effectiveness of Sorafenib for Second-Line Treatment of Advanced Renal Cell Carcinoma

✍ Scribed by Martin Hoyle; Colin Green; Jo Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Moxham; Ken Stein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Temsirolimus for F

✍ Martin Hoyle; Colin Green; Jo Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Mo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Treatment outcomes of sorafenib for firs

✍ Takeshi Ueda; Yusuke Imamura; Atsushi Komaru; Satoshi Fukasawa; Tomokazu Sazuka; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Editorial Comment to Treatment outcomes

✍ Yoshihiko Tomita 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Targeted agents for the treatment of adv

✍ Walter M. Stadler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

Cost-effectiveness evaluation of sunitin

✍ Emiliano Calvo Aller; Pablo Maroto; Noémi Kreif; José Luis González Larriba; Mar 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 451 KB

Temisorlimus in the treatment of advance

✍ Bernard J. Escudier 📂 Article 📅 2007 🏛 PAGEPress Publications 🌐 English ⚖ 121 KB